Determining clinically meaningful decline in preclinical Alzheimer disease
Jul 23, 2019•1 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
Dr. Philip Insel provides the main findings of his paper on determining clinically meaningful decline in preclinical Alzheimer disease.
For the best experience, listen in Metacast app for iOS or Android